1 results match your criteria: "M.B.B.CH Zagazig University[Affiliation]"
Article Synopsis
- Research indicates that direct acting antiviral agents (DAAs) can lead to sustained virologic response (SVR) in chronic HCV patients, potentially improving insulin resistance (IR) and Type 2 diabetes mellitus (T2DM) symptoms.
- A study involving 240 chronic HCV patients showed significant improvements in blood glucose levels and IR scores three months after DAA treatment, with many patients experiencing better diabetes control.
- The findings suggest that eliminating HCV not only helps in viral clearance but also benefits metabolic health, indicating a need for further exploration of the relationship between HCV and diabetes management.